Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c41fad0ea969e1e732c198b72c347192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-521 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2014-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb3746aab9965d2cc9423bb0b96fc6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0698a6025081aaeaf0b1e451da8f26c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e0bcd80946a38680336073c187db0e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_088f774ce77725afebe21167980812a6 |
publicationDate |
2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014186047-A1 |
titleOfInvention |
Yeast-based immunotherapy for chordoma |
abstract |
One embodiment of the invention relates to a method to treat chordoma in an individual who has chordoma. The method includes the step of administering to an individual who has chordoma, an immunotherapeutic composition comprising: (a) a yeast vehicle; and (b) a cancer antigen comprising at least one Brachyury antigen. Another embodiment of the invention relates to the use of an immunotherapeutic composition comprising a yeast vehicle and a cancer antigen comprising at least one Brachyury antigen to chordoma in an individual who has chordoma. Yet another embodiment of the invention relates to the use an immunotherapeutic composition comprising a yeast vehicle. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016303525-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108348586-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018529318-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108348586-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034740-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7048482-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017023840-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065313-B2 |
priorityDate |
2013-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |